🟢 Femasys is trading 10% up today after UNC Health partnership expands fertility care statewide

Femasys is trading 10.04% up now at $3.07 after continued investor reaction to its August 26, 2026 partnership with UNC Health.

• The agreement will introduce FemVue, SpermVue, and FemaSeed Complete across UNC Health OB/GYN practices statewide, expanding access to fertility diagnostics and first-line treatment.
• The company-specific partnership is the clearest catalyst despite biotech-sector weakness and broader interest-rate uncertainty.